Autoinjectors Market to Reach USD 3.8 billion by 2031, Growth at CAGR 16.2% | Report by Transparency Market Research, Inc.

An autoinjector is a medical device designed to deliver a specific dose of medication, often for self-administration. These devices are typically pre-filled, spring-loaded syringes that make it easier for individuals to inject themselves without hesitation or need for professional assistance.

As per the report published by Transparency Market Research, the global autoinjectors market was worth US$ 1.0 Bn in 2022 and is expected to reach US$ 3.8 Bn by the year 2031 at a CAGR of 16.2 % between 2023 and 2031.

Autoinjectors are typically single-use, disposable devices featuring spring-loaded, prefilled syringes. They are designed for ease of use, allowing patients or untrained individuals to administer the medication themselves. The injection site varies depending on the drug but is commonly the thigh or buttocks.

Request a PDF Sample of this Report Now! https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85651

Eagle’s Eye View of Autoinjectors Market

Autoinjectors are commonly used for medications that need to be administered quickly and precisely, such as epinephrine for severe allergic reactions (e.g., EpiPen), or for chronic conditions like multiple sclerosis. They are designed to be user-friendly, often requiring just a push of a button to deliver the medication.

These medical devices are becoming increasingly popular among patients due to their advantages over conventional devices. The market is expanding, driven by the launch of cost-effective and highly efficient self-injection and wearable devices. These autoinjectors reduce the risk of needle stick injuries, as they deliver precise doses of pre-mixed medications.

The growing adoption of self-injection devices by healthcare professionals is contributing to market growth. Increased awareness of drug delivery systems and rising preference for home-based self-injection among patients are key factors driving this expansion. Additionally, the broad availability of more efficient, user-friendly, and patient-focused products is fueling the demand for autoinjectors.

Moreover, the increasing demand for auto-injector platforms designed for high viscosity and high-volume biologic drug delivery significantly drives the auto-injector market. As biological therapies, which often require precise and consistent dosing, become more prevalent, there is a growing need for advanced delivery systems that can handle these complex formulations. Conventional autoinjectors may struggle with the higher viscosity and larger volumes associated with biologics, creating a demand for specialized platforms such as the AltaVISC Auto-injector.

Altaviz, a designer, manufacturer, and developer of medical devices and drug delivery platforms, is experiencing a surge of interest in the recently announced (October 2023) AltaVISC Auto-injector Platform (AltaVISC). AltaVISC is the first, fully customizable gas-powered auto-injector platform designed specifically for high-viscosity, high-volume biologic therapies. The company continues to invest in the AltaVISC platform with ongoing development of the standard system building blocks (application accelerators) that enable organizations to rapidly customize the platform for a broad variety of applications and accelerate time to market.

These advanced autoinjectors are designed to efficiently deliver these challenging formulations, offering a reliable and patient-friendly solution. This improves the patient experience by allowing for easier self-administration at home and reducing healthcare providers' burden. The customization capabilities of platforms like AltaVISC enable pharmaceutical companies to tailor the devices to specific therapies, accelerating their time to market and meeting the growing demand for biologic treatments.

Autoinjectors Market Report Scope:

Autoinjectors Market - Delving Deeper Region-wise

• North America generated the highest revenue in 2023. The region is expected to maintain its dominance during the forecast period as well.

Increasing incidence of chronic conditions such as diabetes, multiple sclerosis, and rheumatoid arthritis, growing trend towards self-administration of medications at home driven by convenience and the desire to avoid frequent visits to healthcare facilities, ongoing innovations in autoinjector design including features like dose accuracy, ease of use, and safety mechanisms, and favorable healthcare policies, along with insurance coverage for self-injection devices are some of the factors driving autoinjectors market in the region.

Key Players in Autoinjectors Market

Ypsomed Holding AG, Novartis AG, BD, Medmix Healthcare, Eli Lilly and Company, Sanofi, Mylan N.V., Amgen, Inc., SHL Medical AG, and Recipharm AB are some of the leading key players operating in the global industry.

Key Developments at Disposal

In April 2024, Gerresheimer, an innovative systems and solutions provider and global partner for the pharma, biotech, and cosmetics industries, collaborated with the US digital health company RxCap and acquired a minority stake. Under the terms of the agreement, Gerresheimer's subsidiary Center will receive exclusive distribution rights for pharmacies in the U.S. for adherence solutions by RxCap, consisting of connected prescription vial closure devices and complementary cloud-based software.

Autoinjectors Market Segmentation

Type

• Disposable
• Reusable

Technology

• Handheld
• Wearable

Route of Administration

• Subcutaneous
• Intramuscular

Indication

• Multiple Sclerosis
• Rheumatoid Arthritis
• Diabetes
• Anaphylaxis
• Others (Oncology, Immunology, etc.)

End-user

• Homecare Settings
• Hospitals & Clinic

Explore Our Report for Comprehensive Insights! https://www.transparencymarketresearch.com/autoinjectors-market.html

More Trending Reports by Transparency Market Research –

Infant Resuscitators Market - The global infant resuscitators market was valued at US$ 253.1 million in 2022. It is projected to grow at a compound annual growth rate (CAGR) of 5.2% from 2023 to 2031, reaching over US$ 401.4 million by the end of 2031.

Mechanical Thrombectomy Devices Market - The mechanical thrombectomy devices market was valued at US$ 1.1 billion in 2022. It is expected to grow at a CAGR of 6.4% from 2023 to 2031, reaching over US$ 1.8 billion by the end of 2031.

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Transparency Market Research Inc.

CORPORATE HEADQUARTER DOWNTOWN,

1000 N. West Street,

Suite 1200, Wilmington, Delaware 19801 USA

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com    

Email: sales@transparencymarketresearch.com

Follow Us: LinkedIn| Twitter| Blog | YouTube